Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.
Age
18–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of asthma by a physician at least 12 months before Screening Visit.
Treated with medium or high dose inhaled corticosteroid (ICS) plus additional controller for at least 12 months prior to Screening Visit. Subjects must maintain a stable ICS dose regimen during the 4 weeks prior to the Screening Visit.
Forced Expiratory Volume in 1 second (FEV1) of ≤ 85% of predicted normal
Demonstrated reversibility of at least 12% in FEV1
Evidence of uncontrolled asthma
Eosinophilic asthma
No changes in ICS dose and compliant with standard of care asthma therapy during run-in period.
